Verrica Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
15.12.23
/
50%
€5.10
Target price
15.12.24
€9.18
Performance (%)
-86.93%
End price
16.12.24
€0.67
Summary
This prediction ended on 16.12.24 with a price of €0.67. Massive losses of -86.93% were the result for the BUY prediction by Jefferies_Financial_. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten